Frequency of serological markers of rheumatoid arthritis in patients with IgA anti‐β2 glycoprotein I antibodies
Aim To determine the frequency of serological markers of RA in patients with anti‐β2 glycoprotein I antibodies (aβ2GPI) of IgA isotype. Material and Methods A retrospective study was conducted on 67 patients with aβ2GPI‐IgA. Ninety healthy blood donors (HBD) were used as a control group. IgG anti‐cy...
Saved in:
Published in | Journal of clinical laboratory analysis Vol. 36; no. 7; pp. e24537 - n/a |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
John Wiley & Sons, Inc
01.07.2022
John Wiley and Sons Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Aim
To determine the frequency of serological markers of RA in patients with anti‐β2 glycoprotein I antibodies (aβ2GPI) of IgA isotype.
Material and Methods
A retrospective study was conducted on 67 patients with aβ2GPI‐IgA. Ninety healthy blood donors (HBD) were used as a control group. IgG anti‐cyclic citrullinated peptides antibodies (CCP‐Ab) and rheumatoid factors (RF) IgG, IgA, and IgM were detected by enzyme‐linked immunosorbent assay (ELISA).
Results
Seventeen patients and eight HBD had CCP‐Ab and/or RF (25.4% vs. 8.9%, p = 0.005, CI 95% [14.95; 35.79], odds ratio = 3.5). The frequency of CCP‐Ab was significantly higher in patients than in healthy subjects (14.9% vs. 3.3%, p = 0.009). IgA isotype of RF was significantly higher in patients than in controls (7.5% vs. 0%, p = 0.02). In male patients, CCP‐Ab and/or RF were more frequent than in healthy male subjects (37.5% vs. 11.8%, p = 0.02). In patients, no correlation was found between the levels of aβ2GPI‐IgA and CCP‐Ab (r = 0.082, p = 0.51). There was no correlation between the level aβ2GPI‐IgA and the level of the isotypes of RF (IgG, IgA, and IgM) in patients (r = 0.1, p = 0.37; r = 0.17, p = 0.17 and r = 0.07, p = 0.59 respectively).
Conclusion
Frequencies of CCP‐Ab and RF are high in patients with aβ2GPI‐IgA suggesting that these patients are susceptible to developing RA.
Frequency of CCP‐Ab and RF in patients with IgA anti‐β2 glycoprotein I antibodies. |
---|---|
AbstractList | AimTo determine the frequency of serological markers of RA in patients with anti‐β2 glycoprotein I antibodies (aβ2GPI) of IgA isotype.Material and MethodsA retrospective study was conducted on 67 patients with aβ2GPI‐IgA. Ninety healthy blood donors (HBD) were used as a control group. IgG anti‐cyclic citrullinated peptides antibodies (CCP‐Ab) and rheumatoid factors (RF) IgG, IgA, and IgM were detected by enzyme‐linked immunosorbent assay (ELISA).ResultsSeventeen patients and eight HBD had CCP‐Ab and/or RF (25.4% vs. 8.9%, p = 0.005, CI 95% [14.95; 35.79], odds ratio = 3.5). The frequency of CCP‐Ab was significantly higher in patients than in healthy subjects (14.9% vs. 3.3%, p = 0.009). IgA isotype of RF was significantly higher in patients than in controls (7.5% vs. 0%, p = 0.02). In male patients, CCP‐Ab and/or RF were more frequent than in healthy male subjects (37.5% vs. 11.8%, p = 0.02). In patients, no correlation was found between the levels of aβ2GPI‐IgA and CCP‐Ab (r = 0.082, p = 0.51). There was no correlation between the level aβ2GPI‐IgA and the level of the isotypes of RF (IgG, IgA, and IgM) in patients (r = 0.1, p = 0.37; r = 0.17, p = 0.17 and r = 0.07, p = 0.59 respectively).ConclusionFrequencies of CCP‐Ab and RF are high in patients with aβ2GPI‐IgA suggesting that these patients are susceptible to developing RA. Aim To determine the frequency of serological markers of RA in patients with anti‐β2 glycoprotein I antibodies (aβ2GPI) of IgA isotype. Material and Methods A retrospective study was conducted on 67 patients with aβ2GPI‐IgA. Ninety healthy blood donors (HBD) were used as a control group. IgG anti‐cyclic citrullinated peptides antibodies (CCP‐Ab) and rheumatoid factors (RF) IgG, IgA, and IgM were detected by enzyme‐linked immunosorbent assay (ELISA). Results Seventeen patients and eight HBD had CCP‐Ab and/or RF (25.4% vs. 8.9%, p = 0.005, CI 95% [14.95; 35.79], odds ratio = 3.5). The frequency of CCP‐Ab was significantly higher in patients than in healthy subjects (14.9% vs. 3.3%, p = 0.009). IgA isotype of RF was significantly higher in patients than in controls (7.5% vs. 0%, p = 0.02). In male patients, CCP‐Ab and/or RF were more frequent than in healthy male subjects (37.5% vs. 11.8%, p = 0.02). In patients, no correlation was found between the levels of aβ2GPI‐IgA and CCP‐Ab (r = 0.082, p = 0.51). There was no correlation between the level aβ2GPI‐IgA and the level of the isotypes of RF (IgG, IgA, and IgM) in patients (r = 0.1, p = 0.37; r = 0.17, p = 0.17 and r = 0.07, p = 0.59 respectively). Conclusion Frequencies of CCP‐Ab and RF are high in patients with aβ2GPI‐IgA suggesting that these patients are susceptible to developing RA. Frequency of CCP‐Ab and RF in patients with IgA anti‐β2 glycoprotein I antibodies. To determine the frequency of serological markers of RA in patients with anti-β2 glycoprotein I antibodies (aβ2GPI) of IgA isotype. A retrospective study was conducted on 67 patients with aβ2GPI-IgA. Ninety healthy blood donors (HBD) were used as a control group. IgG anti-cyclic citrullinated peptides antibodies (CCP-Ab) and rheumatoid factors (RF) IgG, IgA, and IgM were detected by enzyme-linked immunosorbent assay (ELISA). Seventeen patients and eight HBD had CCP-Ab and/or RF (25.4% vs. 8.9%, p = 0.005, CI 95% [14.95; 35.79], odds ratio = 3.5). The frequency of CCP-Ab was significantly higher in patients than in healthy subjects (14.9% vs. 3.3%, p = 0.009). IgA isotype of RF was significantly higher in patients than in controls (7.5% vs. 0%, p = 0.02). In male patients, CCP-Ab and/or RF were more frequent than in healthy male subjects (37.5% vs. 11.8%, p = 0.02). In patients, no correlation was found between the levels of aβ2GPI-IgA and CCP-Ab (r = 0.082, p = 0.51). There was no correlation between the level aβ2GPI-IgA and the level of the isotypes of RF (IgG, IgA, and IgM) in patients (r = 0.1, p = 0.37; r = 0.17, p = 0.17 and r = 0.07, p = 0.59 respectively). Frequencies of CCP-Ab and RF are high in patients with aβ2GPI-IgA suggesting that these patients are susceptible to developing RA. Frequency of CCP‐Ab and RF in patients with IgA anti‐β2 glycoprotein I antibodies. |
Author | Melayah, Sarra Mechi, Fatma Ghedira, Ibtissem Ghozzi, Mariem Mankaï, Amani |
AuthorAffiliation | 5 High School of Sciences and Techniques of Health Tunis El Manar University Tunis Tunisia 3 LR12SP11, Biochemistry Department Sahloul University Hospital Sousse Tunisia 1 Laboratory of Immunology Farhat Hached Hospital Sousse Tunisia 2 Department of Immunology, Faculty of Pharmacy Monastir University Monastir Tunisia 6 Research Unit "Obesity: Etiopathology and Treatment, UR18ES01" National Institute of Nutrition and Food Technology Tunis Tunisia 4 Research Unit "Epidemiology and Immunogenetics of Viral Infections, LR14SP02" Sahloul University Hospital Sousse Tunisia |
AuthorAffiliation_xml | – name: 1 Laboratory of Immunology Farhat Hached Hospital Sousse Tunisia – name: 2 Department of Immunology, Faculty of Pharmacy Monastir University Monastir Tunisia – name: 3 LR12SP11, Biochemistry Department Sahloul University Hospital Sousse Tunisia – name: 4 Research Unit "Epidemiology and Immunogenetics of Viral Infections, LR14SP02" Sahloul University Hospital Sousse Tunisia – name: 5 High School of Sciences and Techniques of Health Tunis El Manar University Tunis Tunisia – name: 6 Research Unit "Obesity: Etiopathology and Treatment, UR18ES01" National Institute of Nutrition and Food Technology Tunis Tunisia |
Author_xml | – sequence: 1 givenname: Sarra orcidid: 0000-0002-5424-0750 surname: Melayah fullname: Melayah, Sarra email: sarra.125@hotmail.fr organization: Sahloul University Hospital – sequence: 2 givenname: Mariem orcidid: 0000-0003-4455-6513 surname: Ghozzi fullname: Ghozzi, Mariem organization: Sahloul University Hospital – sequence: 3 givenname: Amani orcidid: 0000-0003-2520-9508 surname: Mankaï fullname: Mankaï, Amani organization: National Institute of Nutrition and Food Technology – sequence: 4 givenname: Fatma surname: Mechi fullname: Mechi, Fatma organization: Monastir University – sequence: 5 givenname: Ibtissem surname: Ghedira fullname: Ghedira, Ibtissem organization: Monastir University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35666694$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kc9uEzEQxi3UiqaFCw-ALHFBSNv6z653fUGKIlqCIvUCZ8v2ziYOGzvYu61y4xF4Fh6Eh-BJ6jRtBRyYy0gzP336Zr5TdOSDB4ReUXJOCWEXa9vrc1ZWvH6GJpTIpmANq47QhDRNXTSE8hN0mtKaENJIKp6jE16JXLKcoHgZ4dsI3u5w6HCCGPqwdFb3eKPjV4hpP44rGDd6CK7FOg6r6AaXsPN4qwcHfkj41g0rPF9OsfaD-_39x6-fDC_7nQ3bGAbI5Px-Y0LrIL1Ax53uE7x86Gfoy-WHz7OPxeL6aj6bLgrLBa8LJowQ3IJuDa2rSoqyMS3rOk61ANZpWgkqpekoJ10lDdiKltKKWkJnqtoafobeH3S3o9lAa7PTqHu1jS6ftlNBO_X3xruVWoYbJVktZVlmgbcPAjHkH6VBbVyy0PfaQxiTYqIuCSk5IRl98w-6DmP0-bxMNblqynmm3h0oG0NKEbonM5SofZRqH6W6jzLDr_-0_4Q-ZpcBegBuXQ-7_0ipT7PF9CB6Bwkzry8 |
CitedBy_id | crossref_primary_10_1007_s00404_022_06892_8 |
Cites_doi | 10.1007/s00296-008-0614-8 10.1038/s41584-018-0070-0 10.1007/s00281-017-0630-4 10.1002/art.38131 10.1097/BOR.0000000000000708 10.1016/j.patbio.2011.07.003 10.1080/08916930601061538 10.1016/j.semarthrit.2020.10.003 10.1002/jcla.24249 10.1002/art.22802 10.1002/jcla.23217 10.1093/rheumatology/kev226 10.1016/j.blre.2019.100610 10.1155/2017/4835189 10.3390/cells8070700 10.3390/ijms23020905 10.3389/fimmu.2021.741369 10.1007/s12016-016-8565-4 10.1016/j.molmed.2015.02.006 10.1136/ard.2007.082669 10.1038/s41584-021-00585-3 10.1111/j.1538-7836.2006.01753.x 10.3390/ijms21238972 10.1016/j.jbspin.2019.01.005 10.1093/rheumatology/keab585 10.3389/fimmu.2021.726820 10.3389/fimmu.2019.01031 10.1016/j.immuni.2017.02.006 10.1016/j.autrev.2019.102352 10.1016/j.autrev.2016.01.001 10.1186/s13075-016-0940-2 10.1002/jcla.21723 10.1007/s11926-014-0472-1 10.1007/s00296-007-0351-4 10.1007/s12026-017-8899-x |
ContentType | Journal Article |
Copyright | 2022 The Authors. published by Wiley Periodicals LLC. 2022 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals LLC. 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: 2022 The Authors. published by Wiley Periodicals LLC. – notice: 2022 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals LLC. – notice: 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | 24P WIN NPM AAYXX CITATION 3V. 7QP 7T5 7U9 7X7 7XB 8C1 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ H94 HCIFZ K9. LK8 M0S M7P PIMPY PQEST PQQKQ PQUKI PRINS 7X8 5PM |
DOI | 10.1002/jcla.24537 |
DatabaseName | Wiley Online Library website Wiley Online Library Free Content PubMed CrossRef ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Immunology Abstracts Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Public Health Database (Proquest) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials Biological Science Collection ProQuest Central ProQuest Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences Health & Medical Collection (Alumni Edition) Biological Science Database Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | PubMed CrossRef Publicly Available Content Database ProQuest Central Student ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection AIDS and Cancer Research Abstracts ProQuest Public Health Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Immunology Abstracts ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: BENPR name: AUTh Library subscriptions: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | Melayah et al |
EISSN | 1098-2825 |
EndPage | n/a |
ExternalDocumentID | 10_1002_jcla_24537 35666694 JCLA24537 |
Genre | article Journal Article |
GeographicLocations | Germany |
GeographicLocations_xml | – name: Germany |
GroupedDBID | --- .3N .GA .GJ .Y3 05W 0R~ 10A 1L6 1OB 1OC 1ZS 24P 31~ 33P 3SF 3WU 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5RE 5VS 66C 6PF 702 7PT 7X7 8-0 8-1 8-3 8-4 8-5 8C1 8FI 8FJ 8UM 930 A01 A03 A8Z AAESR AAEVG AAHHS AAONW AAWTL AAZKR ABCQN ABEML ABIJN ABPVW ABUWG ACBWZ ACCFJ ACGFS ACMXC ACPRK ACSCC ACXQS ADBBV ADEOM ADIZJ ADKYN ADPDF ADZMN AEEZP AEIMD AENEX AEQDE AEUQT AFBPY AFKRA AFPWT AFZJQ AHMBA AIWBW AJBDE ALAGY ALIPV ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR ASPBG ATUGU AVUZU AVWKF AZBYB AZFZN AZVAB BAFTC BBNVY BCNDV BDRZF BENPR BFHJK BHBCM BHPHI BMXJE BROTX BRXPI BY8 CCPQU CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DU5 DUUFO EBD EBS EJD EMOBN ESTFP F00 F01 F04 F1Z F5P FEDTE FUBAC FYUFA G-S G.N GNP GODZA GROUPED_DOAJ H.X HBH HCIFZ HF~ HHY HMCUK HVGLF HYE HZ~ IAO IHR IX1 J0M JPC KQQ LAW LC2 LC3 LH4 LITHE LOXES LP6 LP7 LUTES LW6 M65 M7P MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM N04 N05 N9A NF~ NNB O66 O9- OIG OK1 OVD OVEED P2P P2W P2X P2Z P4B P4D PALCI PIMPY PQQKQ Q.N Q11 QB0 QRW R.K RGB RIWAO RJQFR ROL RPM RWI RX1 SAMSI SUPJJ SV3 TEORI TWZ UB1 UKHRP V2E W8V W99 WBKPD WHWMO WIB WIH WIJ WIK WIN WOHZO WQJ WRC WUP WVDHM WXI WXSBR XG1 XPP XV2 ~IA ~WT ITC NPM AAYXX ACRPL ACYXJ CITATION 3V. 7QP 7T5 7U9 7XB 8FE 8FH 8FK AZQEC DWQXO GNUQQ H94 K9. LK8 PQEST PQUKI PRINS 7X8 5PM |
ID | FETCH-LOGICAL-c3637-26b663ceadb17559648bd2ff31a6e2fa156199bf130f59bec5149c679efb57cb3 |
IEDL.DBID | RPM |
ISSN | 0887-8013 |
IngestDate | Tue Sep 17 21:27:26 EDT 2024 Fri Oct 25 05:11:39 EDT 2024 Thu Oct 10 18:05:14 EDT 2024 Fri Dec 06 02:06:58 EST 2024 Sat Sep 28 08:20:01 EDT 2024 Sat Aug 24 01:03:26 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Keywords | antiphospholipid syndrome rheumatoid factors anti-cyclic citrullinated peptides antibodies rheumatoid arthritis anti-β2 glycoprotein I antibodies |
Language | English |
License | Attribution 2022 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals LLC. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3637-26b663ceadb17559648bd2ff31a6e2fa156199bf130f59bec5149c679efb57cb3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0003-4455-6513 0000-0003-2520-9508 0000-0002-5424-0750 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279944/ |
PMID | 35666694 |
PQID | 2688887133 |
PQPubID | 105667 |
PageCount | 6 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_9279944 proquest_miscellaneous_2674004300 proquest_journals_2688887133 crossref_primary_10_1002_jcla_24537 pubmed_primary_35666694 wiley_primary_10_1002_jcla_24537_JCLA24537 |
PublicationCentury | 2000 |
PublicationDate | July 2022 |
PublicationDateYYYYMMDD | 2022-07-01 |
PublicationDate_xml | – month: 07 year: 2022 text: July 2022 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: New York – name: Hoboken |
PublicationTitle | Journal of clinical laboratory analysis |
PublicationTitleAlternate | J Clin Lab Anal |
PublicationYear | 2022 |
Publisher | John Wiley & Sons, Inc John Wiley and Sons Inc |
Publisher_xml | – name: John Wiley & Sons, Inc – name: John Wiley and Sons Inc |
References | 2019; 8 2012; 60 2015; 17 2017; 2017 2013; 65 2019; 10 2006; 39 2017; 65 2017; 46 2015; 54 2020; 39 2022; 23 2019; 18 2006; 4 2020; 34 2002; 80 2020; 32 2016; 18 2007; 56 2021; 51 2016; 15 2021; 13 2017; 53 2021; 12 2015; 29 2019; 86 2017; 39 2008; 29 2021; 17 2015; 21 2008; 67 2022; 36 2020; 21 2021; 61 2018; 14 2007; 27 e_1_2_7_6_1 e_1_2_7_5_1 Shapiro SC (e_1_2_7_12_1) 2021; 13 e_1_2_7_4_1 e_1_2_7_3_1 e_1_2_7_9_1 e_1_2_7_8_1 e_1_2_7_7_1 e_1_2_7_19_1 e_1_2_7_18_1 e_1_2_7_17_1 e_1_2_7_16_1 e_1_2_7_2_1 e_1_2_7_15_1 e_1_2_7_14_1 e_1_2_7_13_1 e_1_2_7_11_1 e_1_2_7_10_1 e_1_2_7_26_1 e_1_2_7_27_1 e_1_2_7_29_1 e_1_2_7_30_1 e_1_2_7_25_1 e_1_2_7_31_1 e_1_2_7_24_1 e_1_2_7_32_1 e_1_2_7_23_1 e_1_2_7_33_1 e_1_2_7_22_1 e_1_2_7_34_1 e_1_2_7_21_1 e_1_2_7_35_1 e_1_2_7_20_1 e_1_2_7_36_1 e_1_2_7_37_1 e_1_2_7_38_1 Fakhfakh R (e_1_2_7_28_1) 2002; 80 |
References_xml | – volume: 2017 start-page: 4835189 year: 2017 article-title: Intestinal dysbiosis and rheumatoid arthritis: a link between gut microbiota and the pathogenesis of rheumatoid arthritis publication-title: J Immunol Res – volume: 53 start-page: 1 issue: 1 year: 2017 end-page: 13 article-title: Anti‐phospholipid antibodies and smoking: an overview publication-title: Clin Rev Allergy Immunol – volume: 65 start-page: 524 issue: 2 year: 2017 end-page: 531 article-title: Anti‐mutated citrullinated vimentin antibodies in antiphospholipid syndrome: diagnostic value and relationship with clinical features publication-title: Immunol Res – volume: 32 start-page: 289 issue: 3 year: 2020 end-page: 296 article-title: Preclinical rheumatoid arthritis and rheumatoid arthritis prevention publication-title: Curr Opin Rheumatol – volume: 51 start-page: 20 issue: 1 year: 2021 end-page: 27 article-title: Beta‐2‐glycoprotein‐I IgA antibodies predict coronary plaque progression in rheumatoid arthritis publication-title: Semin Arthritis Rheum – volume: 39 year: 2020 article-title: The role of beta‐2‐glycoprotein I in health and disease associating structure with function: more than just APS publication-title: Blood Rev – volume: 29 start-page: 59 issue: 1 year: 2008 end-page: 62 article-title: Value of anti‐mutated citrullinated vimentin antibodies in diagnosing rheumatoid arthritis publication-title: Rheumatol Int – volume: 27 start-page: 1125 issue: 12 year: 2007 end-page: 1130 article-title: Diagnostic performances of anti‐cyclic citrullinated peptide antibodies in rheumatoid arthritis publication-title: Rheumatol Int – volume: 56 start-page: 2687 issue: 8 year: 2007 end-page: 2697 article-title: Anti‐beta2‐glycoprotein I antibodies induce monocyte release of tumor necrosis factor alpha and tissue factor by signal transduction pathways involving lipid rafts publication-title: Arthritis Rheum – volume: 39 start-page: 395 issue: 4 year: 2017 end-page: 408 article-title: Genetics of rheumatoid arthritis susceptibility, severity, and treatment response publication-title: Semin Immunopathol – volume: 67 start-page: 1529 issue: 11 year: 2008 end-page: 1534 article-title: Cigarette smoking, disease severity and autoantibody expression in African Americans with recent‐onset rheumatoid arthritis publication-title: Ann Rheum Dis – volume: 34 issue: 6 year: 2020 article-title: IgA is the predominant isotype of anti‐β2 glycoprotein I antibodies in rheumatoid arthritis publication-title: J Clin Lab Anal – volume: 46 start-page: 183 issue: 2 year: 2017 end-page: 196 article-title: Immunopathogenesis of rheumatoid arthritis publication-title: Immunity – volume: 4 start-page: 295 issue: 2 year: 2006 end-page: 306 article-title: International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) publication-title: J Thromb Haemost – volume: 18 issue: 9 year: 2019 article-title: Antiphospholipid syndrome's genetic and epigenetic aspects publication-title: Autoimmun Rev – volume: 15 start-page: 354 issue: 4 year: 2016 end-page: 374 article-title: Smoke and autoimmunity: the fire behind the disease publication-title: Autoimmun Rev – volume: 17 start-page: 224 issue: 4 year: 2021 end-page: 237 article-title: The gut‐joint axis in rheumatoid arthritis publication-title: Nat Rev Rheumatol – volume: 13 issue: 5 year: 2021 article-title: Biomarkers in rheumatoid arthritis publication-title: Cureus – volume: 65 start-page: 3186 issue: 12 year: 2013 end-page: 3193 article-title: Value of isolated IgA anti‐β2‐glycoprotein I positivity in the diagnosis of the antiphospholipid syndrome publication-title: Arthritis Rheum – volume: 10 year: 2019 article-title: The IgA isotype of anti‐β2 glycoprotein I antibodies recognizes epitopes in domains 3, 4, and 5 that are located in a lateral zone of the molecule (L‐shaped) publication-title: Front Immunol – volume: 8 start-page: 700 issue: 7 year: 2019 article-title: Mucosa‐environment interactions in the pathogenesis of rheumatoid arthritis publication-title: Cell – volume: 39 start-page: 683 issue: 8 year: 2006 end-page: 690 article-title: Microparticles as mediators of cellular cross‐talk in inflammatory disease publication-title: Autoimmunity – volume: 54 start-page: 2042 issue: 11 year: 2015 end-page: 2050 article-title: Examining the prevalence of non‐criteria anti‐phospholipid antibodies in patients with anti‐phospholipid syndrome: a systematic review publication-title: Rheumatology (Oxford) – volume: 14 start-page: 542 issue: 9 year: 2018 end-page: 557 article-title: Rheumatoid arthritis and the mucosal origins hypothesis: protection turns to destruction publication-title: Nat Rev Rheumatol – volume: 29 start-page: 32 issue: 1 year: 2015 end-page: 36 article-title: High frequency of antiphospholipid antibodies in primary biliary cirrhosis publication-title: J Clin Lab Anal – volume: 17 start-page: 472 issue: 1 year: 2015 article-title: The role of the gut microbiota in the pathogenesis of antiphospholipid syndrome publication-title: Curr Rheumatol Rep – volume: 36 issue: 3 year: 2022 article-title: Frequency of serological markers of rheumatoid arthritis in adult patients with active celiac disease publication-title: J Clin Lab Anal – volume: 12 year: 2021 article-title: Antiphospholipid antibody assays in 2021: looking for a predictive value in addition to a diagnostic one publication-title: Front Immunol – volume: 23 start-page: 905 issue: 2 year: 2022 article-title: Rheumatoid arthritis: pathogenic roles of diverse immune cells publication-title: Int J Mol Sci – volume: 21 issue: 23 year: 2020 article-title: The weight of IgA anti‐β2glycoprotein I in the antiphospholipid syndrome pathogenesis: closing the gap of seronegative antiphospholipid syndrome publication-title: Int J Mol Sci – volume: 60 start-page: 291 issue: 5 year: 2012 end-page: 295 article-title: Anti‐cardiolipin and anti‐beta 2‐glycoprotein I antibodies in celiac disease publication-title: Pathol Biol (Paris) – volume: 61 start-page: 2124 year: 2021 end-page: 2131 article-title: RETRO study group. IgA anti‐citrullinated protein antibodies (IgA ACPA) are associated with flares during DMARD tapering in rheumatoid arthritis publication-title: Rheumatology (Oxford) – volume: 86 start-page: 562 issue: 5 year: 2019 end-page: 567 article-title: Pathogenic effects of anti‐citrullinated protein antibodies in rheumatoid arthritis – role for glycosylation publication-title: Joint Bone Spine – volume: 12 year: 2021 article-title: Evaluation of the diagnostic value of non‐criteria antibodies for antiphospholipid syndrome patients in a Chinese cohort publication-title: Front Immunol – volume: 80 start-page: 350 year: 2002 end-page: 356 article-title: Tobacco use in Tunisia: behaviour and awareness publication-title: Bull World Health Organ – volume: 18 start-page: 43 year: 2016 article-title: Rheumatoid factor isotypes in relation to antibodies against citrullinated peptides and carbamylated proteins before the onset of rheumatoid arthritis publication-title: Arthritis Res Ther – volume: 21 start-page: 233 issue: 4 year: 2015 end-page: 244 article-title: Autoimmune host‐microbiota interactions at barrier sites and beyond publication-title: Trends Mol Med – ident: e_1_2_7_20_1 doi: 10.1007/s00296-008-0614-8 – ident: e_1_2_7_33_1 doi: 10.1038/s41584-018-0070-0 – ident: e_1_2_7_18_1 doi: 10.1007/s00281-017-0630-4 – ident: e_1_2_7_23_1 doi: 10.1002/art.38131 – ident: e_1_2_7_31_1 doi: 10.1097/BOR.0000000000000708 – ident: e_1_2_7_8_1 doi: 10.1016/j.patbio.2011.07.003 – ident: e_1_2_7_14_1 doi: 10.1080/08916930601061538 – ident: e_1_2_7_19_1 doi: 10.1016/j.semarthrit.2020.10.003 – ident: e_1_2_7_29_1 doi: 10.1002/jcla.24249 – ident: e_1_2_7_16_1 doi: 10.1002/art.22802 – ident: e_1_2_7_10_1 doi: 10.1002/jcla.23217 – ident: e_1_2_7_5_1 doi: 10.1093/rheumatology/kev226 – ident: e_1_2_7_2_1 doi: 10.1016/j.blre.2019.100610 – volume: 13 start-page: e15063 issue: 5 year: 2021 ident: e_1_2_7_12_1 article-title: Biomarkers in rheumatoid arthritis publication-title: Cureus contributor: fullname: Shapiro SC – ident: e_1_2_7_34_1 doi: 10.1155/2017/4835189 – ident: e_1_2_7_36_1 doi: 10.3390/cells8070700 – ident: e_1_2_7_11_1 doi: 10.3390/ijms23020905 – ident: e_1_2_7_7_1 doi: 10.3389/fimmu.2021.741369 – ident: e_1_2_7_27_1 doi: 10.1007/s12016-016-8565-4 – ident: e_1_2_7_38_1 doi: 10.1016/j.molmed.2015.02.006 – ident: e_1_2_7_26_1 doi: 10.1136/ard.2007.082669 – ident: e_1_2_7_35_1 doi: 10.1038/s41584-021-00585-3 – ident: e_1_2_7_4_1 doi: 10.1111/j.1538-7836.2006.01753.x – ident: e_1_2_7_6_1 doi: 10.3390/ijms21238972 – ident: e_1_2_7_13_1 doi: 10.1016/j.jbspin.2019.01.005 – ident: e_1_2_7_32_1 doi: 10.1093/rheumatology/keab585 – volume: 80 start-page: 350 year: 2002 ident: e_1_2_7_28_1 article-title: Tobacco use in Tunisia: behaviour and awareness publication-title: Bull World Health Organ contributor: fullname: Fakhfakh R – ident: e_1_2_7_3_1 doi: 10.3389/fimmu.2021.726820 – ident: e_1_2_7_22_1 doi: 10.3389/fimmu.2019.01031 – ident: e_1_2_7_15_1 doi: 10.1016/j.immuni.2017.02.006 – ident: e_1_2_7_17_1 doi: 10.1016/j.autrev.2019.102352 – ident: e_1_2_7_25_1 doi: 10.1016/j.autrev.2016.01.001 – ident: e_1_2_7_30_1 doi: 10.1186/s13075-016-0940-2 – ident: e_1_2_7_9_1 doi: 10.1002/jcla.21723 – ident: e_1_2_7_37_1 doi: 10.1007/s11926-014-0472-1 – ident: e_1_2_7_21_1 doi: 10.1007/s00296-007-0351-4 – ident: e_1_2_7_24_1 doi: 10.1007/s12026-017-8899-x |
SSID | ssj0008916 |
Score | 2.3356075 |
Snippet | Aim
To determine the frequency of serological markers of RA in patients with anti‐β2 glycoprotein I antibodies (aβ2GPI) of IgA isotype.
Material and Methods
A... To determine the frequency of serological markers of RA in patients with anti-β2 glycoprotein I antibodies (aβ2GPI) of IgA isotype. A retrospective study was... AimTo determine the frequency of serological markers of RA in patients with anti‐β2 glycoprotein I antibodies (aβ2GPI) of IgA isotype.Material and MethodsA... AIMTo determine the frequency of serological markers of RA in patients with anti-β2 glycoprotein I antibodies (aβ2GPI) of IgA isotype. MATERIAL AND METHODSA... Frequency of CCP‐Ab and RF in patients with IgA anti‐β2 glycoprotein I antibodies. |
SourceID | pubmedcentral proquest crossref pubmed wiley |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | e24537 |
SubjectTerms | Antibodies antiphospholipid syndrome anti‐cyclic citrullinated peptides antibodies anti‐β2 glycoprotein I antibodies Autoimmune diseases Blood donors Citrulline Disease Enzyme-linked immunosorbent assay Females Glycoprotein I Glycoproteins Hepatitis Immunoglobulin A Immunoglobulin G Immunoglobulin M Isotypes Lupus Males Peptides Pregnancy Rheumatoid arthritis rheumatoid factors Serology Thrombosis Tumor necrosis factor-TNF |
SummonAdditionalLinks | – databaseName: Public Health Database (Proquest) dbid: 8C1 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NTtwwEB5RkKpeED9tCX8yoqdKKdixnfUJrVasANGeisQtsh2b3YomkGUP3PoIfRYehIfok3TsZBcQErcodpTEM575xh5_A_DF9jSGxlSm1EqV8pKJ1KjSpYxrzUTp0SVGts8f8uSCn12Ky27BbdKlVc5sYjTUZW3DGvkBkxir9UJIdXRzm4aqUWF3tSuh8Q6WaHB04aT44CnFo6di6dM4kdASZ3N6Unbwy17rb4yLUP_8uUN6hTJfJ0s-B7HRCw1XYLmDj6TfynsVFly1Bu-_dxvk69AMmzY3-p7UnqB6zWwb-R3ycJpJuN2M3BSBaj0uCSrOKNIakXFFOo7VCQmLs-T0qk9w2Mf__vx9fGDk6vre1pHVAXuexhZThxTEj3AxPP45OEm7sgqpzWSWp0wahBkWVcggdhBK8p4pmfcZ1dIxrzGio0oZj97NC4UyRkylrMyV80bk1mSfYLGqK7cBpOSUKk3R3meKSyuMQN9nHHPcaOoPZQL7s7Etblr2jKLlSWZFkEARJZDA9mzYi24GTYoneSewN29G3Q8bGrpy9TT0yXkkLTtM4HMrpflrMsSpUiqeQP5CfvMOgVf7ZUs1HkV-bcVypTg--TVK-o0vL84G5_14tfn2P2zBBxbOTcQ8321YvGumbgfRzJ3ZjSr7H8dq9rQ priority: 102 providerName: ProQuest – databaseName: Wiley Online Library website dbid: 24P link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3NTtwwEB7xIyEuFYX-pNDKCE6VAsSxnbXUywqxAgSIA0jcItux2UU0qbLsgVsfgWfhQXgInqRjJxtYIVXiFsVjJZoZz3y2x58Btk1P4dQ4EXFihIxZQXmsZWFjypSivHCYEgPb55k4vGTHV_xqDn5Nz8I0_BDdgpsfGSFe-wGu9Hj3hTT0xtyqHcp4ms3DIuIa4e8voOy8i8M9GS4-DcMI43DakZPS3Ze-s-noDcZ8Wyr5GsKGHDRYgQ8teCT9xtofYc6Wq7B02m6Pr0E9qJvK6HtSOYLONY1s5LevwqnH_nU9tBOEqdWoIOg2w0BqREYlaRlWx8QvzZKj6z5BpY-e_z48PVJyfXtvqsDpgJJHoUVXvgDxE1wODi72D-P2UoXYpCLNYio0ggyDDqQROXApWE8X1Lk0UcJSp1CRiZTaYW5zXKKFEVFJIzJpneaZ0elnWCir0n4FUrAkkSrBaJ9KJgzXHDOfttQyrRK3JyLYmuo2_9NwZ-QNSzLNvQXyYIEINqZqz9vxM86pwJl5z0-gI9jsmtHz_XaGKm018TIZC5RlexF8aazUfSZFlCqEZBFkM_brBDyr9mxLORoGdm1JMykZ9vwZLP2fP8-P90_64enbe4TXYZn6MxSh5ncDFu7qif2OyOZO_wgO_A9cIPfh priority: 102 providerName: Wiley-Blackwell |
Title | Frequency of serological markers of rheumatoid arthritis in patients with IgA anti‐β2 glycoprotein I antibodies |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjcla.24537 https://www.ncbi.nlm.nih.gov/pubmed/35666694 https://www.proquest.com/docview/2688887133 https://search.proquest.com/docview/2674004300 https://pubmed.ncbi.nlm.nih.gov/PMC9279944 |
Volume | 36 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NatwwEB6yKZReQtNfp-mi0p4K3o1lSbaO2yVLEpqwhAb2ZixZzrrs2sGbPeSWR8iz9EH6EH2SjmR7yRLooRdhLIFszWjmG2n0CeCLjlMMjQPhB1pIn2WU-0pmxqcsTSnPcnSJju3zQpxcsbMZn-0A787CuKR9rYpBuVgOymLucitvlnrY5YkNp-djSSMpGRv2oIfutwvRW_MbS3ffqZs9aH7DDScpHf7Ui3RAGQ_t1XshAhkhJNt2SE9Q5tNkyccg1nmhyUvYa-EjGTWfuQ87pnwFz8_bDfLXUE_qJjf6jlQ5QfXqbBtZ2jycemVf13OzRqBaFRnB_507WiNSlKTlWF0RuzhLTq9HBIe9-HP_8PsXJdeLO105VgdseepqVGVTEN_A1eT4x_jEb69V8HUowsinQiHM0KhCCrEDl4LFKqN5HgapMDRPMaILpFQ5erecS5QxYiqpRSRNrnikVfgWdsuqNO-BZCwIZBqgvQ8lE5orjr5PGWqYSoP8SHjwuRvb5KZhz0ganmSaWGEkThgeHHbDnrQzaJVQgbF5bENoDz5tqlH37YZGWppqbdtEzJGWHXnwrpHSpptOvB5EW_LbNLC82ts1qG6OX7tVLw--Okn_48uTs_H3kXs6-O9uPsALao9UuBTgQ9i9rdfmIwKdW9WHHmVTLKNZhGU8Dvrw7NvxxfSy75YObHlJ-079_wJPegYJ |
link.rule.ids | 230,314,727,780,784,864,885,1375,11562,12056,12223,21388,27924,27925,31719,31720,33266,33267,33744,33745,43310,43579,43805,46052,46294,46476,46718,50814,50923,53791,53793,73745,74014,74302 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NbtQwEB7BVgIuqPyVQAEjOCGFNo7trE_VUnW1W7YrhFqptyh27O6ikpRs99Abj8Cz8CA8RJ-kY8cbWlXqLYodJfE3mflsT74B-Kj7BU6NExEnWsiYlZTHSpYmpqwoKC8thkSv9jkVoyO2f8yPw4LbIqRVrnyid9Rlrd0a-RYVOFfruynVztmv2FWNcruroYTGfVhzyum8B2tf9qbfvne-uC998VP_KaEvTjuBUrr1Q58WnynjrgL69ZB0i2feTpe8TmN9HBquw-NAIMmgRfwJ3DPVU3hwELbIn0EzbNrs6AtSW4IGtvJu5KfLxGkW7nQzM0ukqvW8JGg6My9sROYVCSqrC-KWZ8n4ZEBw4OeXv__8-0vJyemFrr2uA_Yc-xZVuyTE53A03DvcHcWhsEKsU5FmMRUKiYZGI1LIHrgUrK9Kam2aFMJQW-CcLpFSWYxvlktEGVmV1CKTxiqeaZW-gF5VV-YlkJIliSwS9PipZEJzxTH6KUMNU0Vit0UEH1Zjm5-1-hl5q5RMc4dA7hGIYHM17Hn4hhb5f8QjeN81o_W7LY2iMvXS9cmYly3bjmCjRam7TYpMVQjJIshu4Nd1cMraN1uq-cwrbEuaScnwyk8e6TuePN_fnQz80au73-EdPBwdHkzyyXj69TU8ou4vCp_1uwm982Zp3iC3OVdvgwFfAQv1-0I |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NbtQwEB7BVqq4IMpfAwWM4IQUduPYzvpULaWrbimrClGptyh27O6ikpRs99Abj8Cz8CB9CJ6kY8cbWlXqLYod5ecbz3y2J98AvNfDAqfGiYgTLWTMSspjJUsTU1YUlJcWQ6JX-5yKvSO2f8yPQ_7TIqRVrnyid9Rlrd0aeZ8KnKsN3ZSqb0NaxOHn8fbZr9hVkHI7raGcxn1Yw6g4oD1Y-7Q7PfzW-eWh9IVQ_bBCv5x2YqW0_0OfFh8p464a-vXwdItz3k6dvE5pfUwaP4KHgUySUYv-Btwz1WNY_xq2y59AM27aTOkLUluCxrbydOSny8ppFu50MzNLpK31vCRoRjMvckTmFQmKqwvilmrJ5GREEIT5v99_Lv9ScnJ6oWuv8YA9J75F1S4h8SkcjXe_7-zFochCrFORZjEVCkmHRoNSyCS4FGyoSmptmhTCUFvg_C6RUlmMdZZLRBwZltQik8YqnmmVPoNeVVdmE0jJkkQWCXr_VDKhueIYCZWhhqkisQMRwbvVt83PWi2NvFVNprlDIPcIRLC1-ux5GE-L_D_6EbztmnEkuO2NojL10vXJmJcwG0TwvEWpu02KrFUIySLIbuDXdXAq2zdbqvnMq21LmknJ8MoPHuk7njzf3zkY-aMXd7_DG1hH280PJtMvL-EBdT9U-ATgLeidN0vzCmnOuXod7PcKi07_bw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Frequency+of+serological+markers+of+rheumatoid+arthritis+in+patients+with+IgA+anti%E2%80%90%CE%B22+glycoprotein+I+antibodies&rft.jtitle=Journal+of+clinical+laboratory+analysis&rft.au=Melayah%2C+Sarra&rft.au=Ghozzi%2C+Mariem&rft.au=Manka%C3%AF%2C+Amani&rft.au=Mechi%2C+Fatma&rft.date=2022-07-01&rft.issn=0887-8013&rft.eissn=1098-2825&rft.volume=36&rft.issue=7&rft.epage=n%2Fa&rft_id=info:doi/10.1002%2Fjcla.24537&rft.externalDBID=10.1002%252Fjcla.24537&rft.externalDocID=JCLA24537 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0887-8013&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0887-8013&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0887-8013&client=summon |